Summary. The effects of prostaglandin E 1 (PGE 1) and histamine on activation of superoxide (O ~-) formation, exocytosis of fi-glucuronidase and aggregation in human neutrophils and HL-60 leukemic cells were studied. PGEb histamine and impromidine, a potent Hz-agonist, inhibited O2 formation in neutrophils induced by the chemotactic peptide, N-formyl-L-methionyl-L-leucyl-L-phenylalanine (tMet-Leu-Phe) with ICso values of 0.5 gM, 8 ~tM and 2 gM, respectively. The full Hl-agonist and weak partial Hzagonist, betahistine, was much less potent and effective than histamine. Dibutyryl cyclic AMP and forskolin mimicked the effects of histamine and PGE1 on O~ formation. The Hz-antagonist, famotidine, competitively reversed histamine-induced inhibition of O2 formation with a pA2 value of 7.5. Histamine inhibited O2 formation when added prior to or after fMet-Leu-Phe, fMet-Leu-Phe-induced aggregation and release of fl-glucuronidase in neutrophils were less sensitive to inhibition by PGE1, histamine, dibutyryl cyclic AMP and forskolin than O~-formation. The inhibitor of cyclic AMP-specific phosphodiesterase, rac-4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (Ro 20-1724), additively enhanced the inhibitory effects of histamine and PGE1 on the above cell functions. In HL-60 cells differentiated by dimethyl sulfoxide or dibutyryl cyclic AMP, histamine, impromidine and PGE1 but not betahistine inhibited fMet-Leu-Phe-induced O~ formation as well. Our data suggest that histamine inhibits activation of neutrophils and HL-60 cells via Hz-receptors through activation of adenylyl cyclase and increased formation of cyclic AMP. As stimulated basophils and mast cells release high quantities of histamine, this intercellular signal molecule may play an inhibitory role in the activation of cytotoxic functions of myeloid cells.
Introduction
Human neutrophils play an important role in the pathogenesis of inflammatory processes and are activated by a variety of intercellular signal molecules such as formyl peptides, platelet activating factor (PAF) and ATP (Malech and Gallin 1987; Sandborg and Smolen 1988; Kuhns et al. 1988 ; Seifert et al. 1989c) . Upon exposure to the formyl peptide, NSend offprint requests to R. Seifert at the above address formyl-L-methionyl-L-leucyl-L-phenylalanine (fMet-LeuPhe), neutrophils generate superoxide anions (02), the formation of which is catalyzed by NADPH oxidase (Rossi 1986; Seifert et al. 1989a-c) . PAF and ATP potentiate fMet-Leu-Phe-induced 02 formation (Dewald and Baggiolini 1985; Kuhns et al. 1988; Ward et al. 1988; Seifert et al. 1989c ). In addition, fMet-Leu-Phe induces aggregation and exocytosis of fi-glucuronidase (Korchak et al. 1984; Seifert et al. 1989c) . Receptors for formyl peptides, PAF and ATP couple to guanine nucleotide-binding proteins (G-proteins) , stimulating phospholipase C with consequent activation of protein kinase C and calcium mobilization (Rossi 1986; Dubyak et al. 1988; Kuhns et al. 1988; Seifert et al. 1989a, b) . Activation of aggregation and exocytosis may involve calcium-dependent processes and activation of protein kinase C (Sandborg and Smolen 1988) . Of formation is activated by multiple mechanisms involving protein kinase C and direct activation by G-proteins (Rossi 1986; Seifert et al. 1986; Sandborg and Smolen 1988) .
Agents which increase the intracellular concentration of cyclic AMP inhibit 02 formation and exocytosis. Among these agents is the intercellular signal molecule, prostaglandin E1 (PGE1), which activates adenylyl cyclase in human neutrophils (Stolc 1977; Lad et al. 1985; Gryglewski et al. 1987) . In addition, the unspecific inhibitor of phosphodiesterases (PDE), 3-isobutyl-l-methylxanthine (IBMX), and the specific inhibitor of cyclic AMP-specific PDE, rac-4-(3-butoxy-4-methoxybenzyl)-2-imidazolidone (Ro 20-1724) inhibit O~ formation (Lad et al. 1985; Weishaar 1987) .
Histamine is released from stimulated basophils and mast cells and plays an important role in the pathogenesis of inflammatory processes as well (Siraganian 1983; Owen 1987) . Histamine receptors are classified into H1-, H2-and H3-receptors according to the potency order of histaminergic agonists and antagonists (Ash and Schild 1966; Black et al. 1972; Durant et al. 1978; Arrang et al. 1983 Arrang et al. , 1987 Schwartz et al. 1986; Buschauer et al. 1989 ). Occupancy of HI-and H2-receptors by agonists leads to the activation of phospholipase C and adenylyl cyclase, respectively (Schwartz et al. 1986; Buschauer et al. 1989) .
There is a controversy concerning the role of histamine in the regulation of neutrophil functions. On one hand, particle-bound histamine induces O~-formation in alveolar macrophages via HI-receptors (Diaz et al. 1979) . In addition, histamine has been reported to induce the formation of thromboxanes in human neutrophils and to stimulate chemokinesis (Seligmann et al. 1983; Puustinen and Uotila 1984) . On the other hand, histamine has been reported to inhibit chemotaxis and fMet-Leu-Phe-induced O~ forma-tion in human neutrophils (Seligmann et al. 1983) . With respect to the release of/~-glucuronidase, histamine has been reported to inhibit exocytosis or to be without effect (Plaut and Lichtenstein 1982) . In addition, histamine activates adenylyl cyclase in membranes of neutrophils and induces accumulation of cyclic AMP in these cells and in HL-60 leukemic cells via Ha-receptors (Stolc 1977; .
These controversial data prompted us to study in detail the role of histamine in the regulation of various neutrophil functions, i.e. O~ formation, exocytosis and aggregation in comparison to PGE1. We here report that histamine inhibits activation of neutrophils and HL-60 cells induced by various intercellular signal molecules. Our results suggest that the effects of histamine involve Ha-receptors and an increase in the intracellular concentration of cyclic AMP.
Materials and methods

Materials.
Impromidine was synthesized according to the method described by Durant et al. (1985) . PAF (1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) was a gift from Dr. S. Nigam (Abteilung fiir Gyn/ikologische Endokrinologie, Universit/itsklinikum Steglitz, Freie Universit/it Berlin, FRG) and Ro 20-1724 was provided by Drs. U. Fischer and H. Gutmann (Hoffmann La-Roche, Basel, Switzerland). Diphenyldramine, fMet-Leu-Phe,
, superoxide dismutase, fcrricytochrome C, IBMX, famotidine, forskolin and p-nitrophenyl-]~-D-glucuronide were from Sigma Chemie (Taufkirchen, FRG). N~-methyl -2-pyridylethylamine (betahistine) and cimetidine were from Aldrich Chemic (Steinheim, FRG). Dibutyryl cyclic AMP (dbcAMP) was from Pharma Waldhof (Diisseldorf, FRG). All cell culture media were from Biochrom (Berlin, FRG). Stock solutions of fMet-Leu-Phe (10raM), Boc-PLPLP (50 raM), cimetidine (100 raM) and CB (5 mg/ml) were prepared in dimethyl sulfoxide (MezSO) and were stored at -20°C. Forskolin (30mM), Ro20-1724 (10raM), PAF (10 raM) and PGE1 (2.5 raM) were dissolved in absolute ethanol and stored at -20 °C. Fresh stock solutions of histamine, betahistine and diphenhydramine (100 mM each in distilled water), famotidine and impromidine (10 mM in distilled water) were prepared daily. Sources of other materials have been described elsewhere (Seifert et al. 1986 (Seifert et al. , 1989a Seifert and Schultz 1987; Seifert and Sch/ichtele 1988) .
Isolation of neutrophils.
Human neutrophils were isolated according to the procedure described by Markert et al. (1984) and Seifert et al. (1989b) . Briefly, blood was obtained from healthy volunteers of either sex who had taken no drugs for at least three weeks. Neutrophils were isolated by dextran sedimentation and centrifugation through FicollHypaque. Cell preparations consisted of more than 98% viable neutrophils as judged by trypan blue dye exclusion and Pappenheim-stained smears.
Cell culture. HL-60 cells were grown in suspension culture in RPMI-1640 medium supplemented with 10 % (by volume) horse serum, 1% (by volume) non-essential amino acids, 2 mM L-glutamine, 50 U/ml penicillin and 50 #g/ml streptomycin in a humidified atmosphere with 7% CO2 at 37°C.
To induce differentiation, HL-60 cells were seeded at a density of 10 6 cells/ml and were cultured for 48 h with 0.2 mM dbcAMP or for 120 h with 160 mM MezSO (Chaplinski and Niedel 1982; Seifert and Schultz 1987; Seifert and Sch/ichtele 1988) . Pappenheim-stained smears showed that MeaSO-and dbcAMP-differentiated HL-60 cells consisted of more than 98% myelocytes or cells beyond this stage.
Assay for superoxide formation. 02 formation was monitored by continuous measurement of ferricytochrome C reduction inhibitable by superoxide dismutase, using an Uvikon 810 dual-beam spectrophotometer (Kontron, Eching, FRG) (Markert et al. 1984; Seifert et al. 1989b ). Reaction mixtures (0.5 ml) contained 0.5-1.0 x 10 6 neutrophils or 2.5 x 10 6 HL-60 cells, 100 gM ferricytochrome C and a buffer consisting of (mM) 138 NaC1, 6 KC1, 1 MgC12, 1 CaC12, 1 NazHPO4, 5 NaHCO3, 5.5 glucose and 20 Hepes/NaOH, pH 7.4. Reaction mixtures were preincubated for 5 min at 37 °C in the presence of the agents indicated. The absolute amounts of O~ generated were calculated.
Assay for release of fl-glucuronidase. Neutrophils (2.5 x 106 ceils) were suspended in 500 gl of the buffer described above and were incubated for 5 rain at 37 °C in the presence of CB (5 ~tg/ml) and in the absence or presence of various agents. Reactions were initiated by the addition of fMet-Leu-Phe. After 10 min, reactions were terminated by placing the tubes onto melting ice. Reaction mixtures were centrifuged for 10 rain at 250 x g at 4 °C. The determinations of/~-glucuronidase and lactate dehydrogenase activities of the supernatant fluids of the reaction mixtures were performed as described (Absolom 1986; Seifert et al. 1989c ). The release of lactate dehydrogenase and/~-glucuronidase (in % of total cellular content) was calculated.
Aggregation of neutrophils. Aggregation was measured by turbidometry (Korchak et al. 1984; Seifert et al. 1989c ). Neutrophils (5 x 10 6 cells) were suspended in 900 gl of the buffer described above. Cells were incubated for 3 rain in the presence or absence of various agents prior to the addition of fMet-Leu-Phe. Aggregation experiments were carried out under constant stirring of cells at 103 rpm, using an Uvikon 810 dual-beam spectrophotometer. The maximum extent of aggregation was calculated.
Results
Superimposed kinetic registrations of 0~-formation in human neutrophils are shown in Fig. 1 . fMet-Leu-Phe at a maximally effective concentration (1 gM) reversibly activated 02~formation which ceased after 6 min (trace 5). In contrast, histamine at a concentration of 1 mM did not activate 02 formation (trace 1). When added 5 min prior to or simultaneously with fMet-Leu-Phe, histamine inhibited 02 formation (trace 2). In addition, histamine rapidly terminated 02 formation when added after fMet-Leu-Phe (traces 3 and 4). Similar results as with histamine were obtained with PGE1 (data not shown). A ten-fold excess of the competitive antagonist of fMet-Leu-Phe, Boc-PLPLP (Jesaitis et al. 1986 ), completely prevented activation of Oy formation by the chemotactic peptide. In addition, Boc-PLPLP rapidly terminated fMet-Leu-Phe-induced 0~-formation (data not shown). Effect of histamine on concentration-response curves for fMet-Leu-Phe-induced O~-formation in human neutrophils. The effect of histamine (1 mM) on fMet-Leu-Phe-induced 02 formation was studied in the presence of CB (1 lag/ml) (Panel A) or in the absence of CB (Panel B). CB and histamine or solvent (control) were added to reaction mixtures 5 min prior to fMet-Leu-Phe, fMetLeu-Phe _+ CB (I); fMet-Leu-Phe _+ CB plus histamine (O). Data shown represent the means of assay triplicates of an experiment carried out with neutrophils of one donor. Assay variation was less than 5%. Similar results were obtained in three experiments carried out with neutrophils of different donors
The effect of histamine (1 mM) on O2 formation in neutrophils was studied in the presence of various concentrations of fMet-Leu-Phe and in the absence or presence of CB (Fig. 2) . In the absence of CB (panel B), fMet-Leu-Phe activated 02 formation with an ECso value of 45 nM and a maximum at 300 nM. In the absence of CB, histamine completely prevented activation of O2 formation induced by fMet-Leu-Phe at concentrations of up to 50 nM. The inhibitory effect of histamine on 02 formation induced by Fig.3 . Concentration-response curves to PGE1 and histaminergic agonists on fMet-Leu-Phe-induced Oy formation in human neutrophils. The effects of PGE1 and histaminergic agonists were studied in the presence of fMet-Leu-Phe (1 gM) and CB (1 g/ml). PGE1 and histaminergic agonists or solvent (control) were added to reaction mixtures 5 min prior to fMet-Leu-Phe. PGE1 (0); histamine (i); impromidine (A); betahistine (,). In the absence of PGE1 and histaminergic agonists, fMet-Leu-Phe induced the formation of 30.8 _+ 2.8 nmoles of O2/106 cells. Data shown are the mean of three experiments carried out with neutrophils of different donors which varied by less than 15% fMet-Leu-Phe at a maximally stimulatory concentration (1 gM) in the absence of CB amounted to 87%. CB potentiates 02 formation by increasing the number of formyl peptide receptors on the plasma membrane (Jesaitis et al. 1986 ). In the presence of CB (panel A), fMet-Leu-Phe activated Of formation with an ECs0 value of 25 nM, reaching a maximum at a concentration of 100 nM. Histamine inhibited 02 formation without altering the ECs0 value and the maximally effective concentration for fMet-Leu-Pheinduced 02 formation. However, histamine completely inhibited 02 formation induced by a very low concentration of fMet-Leu-Phe (10 nM) in the presence of CB. In the presence of CB, histamine inhibited 02 formation induced by fMet-Leu-Phe at a maximally stimulatory concentration by 73%.
The concentration-response functions to PGE 1 and various histaminergic agonists on fMet-Leu-Phe-induced O2 formation in neutrophils were compared (Fig. 3) . PGE1 inhibited fMet-Leu-Phe-induced 02 formation by more than 70%. The effect of PGE1 was half-maximal at 0.5 ~tM and reached a plateau at a concentration of 3 pM. Histamine inhibited 02 formation with an ICso value of 8 gM and was maximally effective at 1 mM. Impromidine, a potent Haagonist (Durant et al. /978) , inhibited 02 formation with an ICso value of 2 gM. The effect ofimpromidine was maximal at a concentration of 30 ~tM. Impromidine and histamine were similarly effective as PGE1. Betahistine is a full agonist at H~-receptors and a weak partial agonist at H2-receptors in various peripheral tissues (Ganellin /982) . In the brain, betahistine is a partial H 1-and H2-agonist (Arrang et al. 1985) . This histaminergic agonist was much less potent and effective than histamine and impromidine to inhibit 02 formation. With respect to the postulated stimulatory effects of H 1-agonists on phagocyte functions we addressed the question whether betahistine may stimulate neutrophils. Betahistine at a concentration of 10 gM did not enhance O2 formation induced by fMet-Leu-Phe at concentrations of 50 nM and 1 gM. As betahistine is a partial H2-agonist, this component may blunt its stimulatory effect on Hi-receptors. Therefore, H2-receptors were blocked with the H2-antagonists, cimetidine or famotidine (Schunack 1987) , at aconcen- tration of 10 gM. Alternatively, H2-receptors were stimulated with impromidine at a concentration of 10 gM. However, even under these conditions betahistine did not potentiate fMet-Leu-Phe-induced Oj formation. In addition, betahistine itself at concentrations of I ~tM -1 mM did not activate O2 formation in the presence or absence of CB (data not shown). Thus, we did not obtain any positive evidence for a stimulatory role of putative H 1-receptors on O2 formation in human neutrophils. The apparent affinity of famotidine for neutrophil H2-receptors was assessed by Schild plot analysis (Fig. 4) (Schild 1947) . Famotidine at concentrations ranging from 0.3-10 gM lead to parallel shifts of the concentration-response curves for histamine to the right. The transformation of these data into the Schild plot presentation was performed according to Tallarida and Jacob t1987). The equation for the regression line is y = -1.03x '+ 7.70 and the intercept with the abscissa (i.e. the pA2 value) is 7.5, These data indicate that famotidine is a competitive antagonist at neutrophil H2-receptors. In addition, the pAz value of famotidine in neutrophils is similar to the one of famotidine in other systems (Schunack 1987) . In contrast to famotidine, the H 1-antagonist, diphenhydramine (Ganellin 1978; Nauta and Rekker 1978) , did not reverse the inhibitory effect of histamine or betahistine on O~-formation (data not shown).
The interactions of inhibitors of PDEs with histamine on O2 formation in human neutrophils were studied (Fig. 5) . IBMX per se inhibited fMet-Leu-Phe-induced O2 formation by up to 60%, the effect of the methylxanthine being halfmaximal at a concentration of 160 gM. The concentrationresponse curve for IBMX was, however, not sigmoid. This abnormality may be due to the fact that IBMX is also an antagonist at neutrophil adenosine A2-receptors (Schmeichel and Thomas 1987). Blockade of A2-receptors by meth- . Thus, both inhibitory and stimulatory components may contribute to the net effect of IBMX on 02 formation. In contrast to IBMX, the specific inhibitor of cyclic AMP-specific PDE, Ro 20-1724, inhibited Oy formation with a sigmoid concentration response function, its effect being half-maximal at 0.13 gM. IBMX plus histamine or Ro 20-1724 plus histamine additively inhibited 02 formation. In addition, histamine shifted the midpoints of the inhibition curves for the PDE inhibitors to the left. The data obtained so far suggest that histamine inhibitis 02 formation through an increase in cyclic AMP. Therefore, the effects of forskolin which directly activates adenylyl cyclase (Barovsky and Brooker 1985) and of the cell-permeable analogue of cyclic AMP, dbcAMP, on O2 formation were studied (Table 1) . Forskolin at a concentration of 30 gM and dbcAMP at a concentration of I mM inhibited fMet-Leu-Phe-induced 02 formation by 23% and 65%, respectively. Table 1 also shows that the combination of histamine plus PGE~ at maximally effective concentrations did not accomplish complete inhibition of O2 formation, regardless of whether Ro 20-1724 was present or not. These data indicate that PGEI alone maximally activates adenylyl cyclase and that histamine, acting through a different receptor, cannot significantly increase the activity of adenylyl cyclase.
The effects of histamine, PGE~ and Ro 20-1724 on 02 formation induced by fMet-Leu-Phe, fMet-Leu-Phe plus PAF or fMet-Leu-Phe plus ATP were compared. PAF (1 gM) and ATP (100 gM) enhanced fMet-Leu-Phe-induced 02 formation in the absence of CB by more than two-fold (Table 2) . Histamine, PGE1 and Ro 20-1724 at maximally effective concentrations inhibited O~ formation induced by These agents also inhibited Oy formation induced by fMetLeu-Phe plus PAF, but this activation was significantly less sensitive to an inhibition by cyclic AMP-increasing agents than the former types of activation. Stimulus-dependent inhibition of O2 formation by cyclic AMP-increasing agents has also been noted in two recent studies (Gryglewski et al. 1987; Seifert et al. 1989a ). The effects of histamine, PGE1, Ro 20-1724, dbcAMP and forskolin and combinations of some of these agents on fMet-Leu-Phe-induced exocytosis of/~-glucuronidase and aggregation were studied. These experiments were performed in order to answer the question whether histamine causes general inhibition of neutrophil activation. At a maximally stimulatory concentration, fMet-Leu-Phe induced the release of 40% of the cellular content of/%glucuronidase (Table 3) . Forskolin did not inhibit fMet-Leu-Phe-induced exocytosis. PGE1, histamine, Ro 20-1724 and dbcAMP inhibited fMet-Leu-Phe-induced release of fl-glucuronidase by 23%, 12%, 17% and 11%, respectively. PGE1 or histamine plus Ro 20-1724 additively inhibited the release of /% glucuronidase. Similarly to 02 formation, histamine did not significantly enhance inhibition of exocytosis caused by PGE1 at a maximally stimulatory concentration both in the absence and presence of Ro 20-/724.
As was the case for fl-glucuronidase release, forskolin did not inhibit tMet-Leu-Phe-induced aggregation. PGE1, histamine and dbcAMP inhibited aggregation induced by fMet-Leu-Phe by 39%, 14% and 10%, respectively (Table 4) . Ro 20-1724 at a subtreshold inhibitory concentration (10 nM) synergistically enhanced the inhibitory effects of PGE~ and histamine.
Finally, we studied the functional role of histamine in the regulation of 02 formation in differentiated HL-60 cells (Table 5) . Upon exposure to fMet-Leu-Phe, dbcAMP-differentiated HL-60 cells generated higher amounts of 02 than The release of/3-glucuronidase induced by fMet-Leu-Phe at a concentration of I gM during an incubation time of 10 min was measured in the absence (control) or presence of various agents or combinations of agents. In the absence of stimulatory and inhibitory agents, the release of/3-glucuronidase and lactate dehydrogenase amounted to 5% of cellular content, none of the agents studied having an effect on the release of lactate dehydrogenase (data not shown). the Me2SO-differentiated ones, possibly due to the expression of higher numbers of formyl peptide receptors in the former cells (Chaplinski and Niedel 1982) . The effectiveness of histaminergic agonists at a concentration of 100 pM to inhibit 02 formation in differentiated HL-60 cells was compared. Histamine and impromidine were similarly effective inhibitors of Of formation both in dbcAMP-and Me2SO-differentiated cells. In contrast, betahistine showed no substantial inhibitory effect. In comparison to histamine, PGE1 was a more effective inhibitor of Of formation in either cell type. In Me2SO-differentiated cells the effects of histaminergic agonists and PGE1 were less prominent than in the dbcAMP-differentiated ones. Thus, the induction of myeloid differentiation of HL-60 cells with dbcAMP does not impair the subsequent inhibition of Of formation by hormonal activators of adenylyl cyclase. These data indicate that the inhibition of Of formation by cyclic AMP-increasing agents is independently regulated of cyclic AMP-induced differentiation.
Discussion
We show here that histamine inhibits Of formation, exocytosis and aggregation in human neutrophils and reduces Of formation in differentiated HL-60 cells. Histaminergic agonists inhibit 02 formation in the potency order impromidine > histamine >> betahistine. In addition, the effects of histamine are competitively antagonized by the H2- To stirred suspensions of neutrophils various agents or soivent (control) were added 3 min prior to the addition of fMet-Leu-Phe (1 ~tM). The extent of aggregation is referred to that induced by fMet-Leu-Phe (i pM). Data shown represent the mean of three experiments carried out with neutrophils of different donors; these varied by less than 15% To induce differentiation, HL-60 cells were cultured for 48 h with 0.2 mM dibutyryl cyclic AMP (dbcAMP) or for 120 h with 160 mM dimethyl sulfoxide (MezSO). Thereafter, cells were harvested and were suspended in the buffer for determination of O~ formation not supplemented with the differentiation-inducing agents. CB (1 gg/ml) plus histamine, impromidine, betahistine, PGE1 or solvent (control) were added to reaction mixtures 5 min prior to fMet-LeuPhe (1 gM). In dbcAMP-and Me2SO-differentiated HL-60 cells, fMet-Leu-Phe induced the formation of 19.2 _+ 4.6 and 12.1 _+ 2.6 nmoles of O2/106 cells, respectively. The percentages shown in the antagonist, famotidine, but not by the Hi-antagonist, diphenhydramine. In agreement with our present results concerning histaminergic inhibition of O2 formation, and reported on a similar potency order of histaminergic agonists to stimulate the accumulation of cyclic AMP in human neutrophils and in HL-60 cells. Histamine and PGE1 are similarly effective inhibitors of the activation of myeloid cell functions. The effects of histamine and PGE a on the accumulation of cyclic AMP Lad et al. 1985) and on inhibition of neutrophil function are additively enhanced by inhibitors of PDEs, such as IBMX and Ro 20-1724, suggesting that both intercellular signal molecules act by a mechanism they have in common. We conclude that histamine inhibits various myeloid functions via H2-receptors through activation of adenylyl cyclase and increased formation of cyclic AMP.
fMet-Leu-Phe induces a transient activation of O~ formation which is rapid in onset. As PGEI and histamine rapidly inhibit O~ formation, the functional response to these agents apparently does not require sustained accumulation of cyclic AMP. Lad et al. (1985) have shown that small increments in the intracellular concentration of cyclic AMP induced by PGE1 are sufficient to inhibit 02 formation. Thus, activation of O~-formation by fMet-Leu-Phe is an inhibitable process which is rapidly terminated by addition of competitive antagonists, e.g. Boc-PLPLP, or by addition of hormonal activators of adenylyl cyclase, e.g. histamine and PGE1.
Histamine does not alter the ECs0 value and the maximally stimulatory concentration of fMet-Leu-Phe-induced O2 formation in neutrophils in the presence of CB, suggesting that histamine does not mediate its effects via modification of the number and/or affinity state of formyl peptide receptors. The differential sensitivity of various classes of stimulatory agonists to an inhibition by histamine suggests that these stimulatory signal molecules activate different signal transduction pathways which are differently modulated by an increase of cyclic AMP. In addition, activation of O~-formation is more sensitive to inhibition by histamine and PGEt than aggregation and exocytosis. Furthermore, forskolin and dbcAMP mimick the differential inhibition profiles induced by histamine and PGE~. Thus, it is not likely that this differential sensitivity is due to the parallel activation of stimulatory H~-receptors and inhibitory Hz-receptors. A greater sensitivity of O~-formation than of exocytosis to inhibition by prostaglandins has recently been noted by Lad et al. (1985) . All these data also suggest that differential sensitivity of G-proteins to a cyclic AMP-mediated inhibition of their function is not involved in this phenomenon as dbcAMP and forskolin act at sites distal from G-proteins. Possibly, protein kinase A-catalyzed phosphorylation reactions differently affect the functional state of proteins involved in the regulation of various effector systems, finally leading to activation of 02 formation, exocytosis and aggregation.
There is recent evidence that platelet products modulate O2 formation in human neutrophils. Platelets synergistically enhance and inhibit O2 formation via the release of ATP and prostaglandins, respectively (Ward et al. 1988; Metha et al. 1988 ). In addition, PAF which is secreted from neutrophils, basophils and mast cells potentiates fMet-LeuPhe-induced O~-formation (Siraganian 1983; Dewald and Baggiolini 1985; Seifert et al. 1989c ). We show here that histamine, PGE1 and Ro 20-1724 inhibit O2 formation induced by fMet-Leu-Phe, fMet-Leu-Phe plus PAF or fMetLeu-Phe plus ATP. Basophils and mast cells release high quantities of histamine upon stimulation with various intercellular signal molecules such as IgE, complement C5a and fMet-Leu-Phe (Siraganian 1983; Warner et al. 1987) . These findings suggest that basophils via the release of histamine may play an inhibitory role in the formyl-peptide-, PAFand ATP-induced activation of O2 formation. These results support the concept that various types of blood cells communicate via the release of intercellular signal molecules to regulate cytotoxic functions of neutrophils. In addition, histamine may play a negative feed-back role in the regulation of cytotoxic functions of basophils and mast cells themselves, as these cells generate O~-as well (Henderson and Kaliner 1978; Kitagawa et al. 1980 ).
